Amarin | AMRN - Action





Action Changement Date
AbbVie USD 5.05B 98M 2026-03
Alnylam Pharmaceuticals USD 200.15M 117.43M 2026-03
Amarin USD 183.58M 12.32M 2026-03
AstraZeneca USD 6.57B 13M 2026-03
BioCryst Pharmaceuticals USD 5.98M 587K 2026-03
Esperion Therapeutics USD 104.21M 915K 2026-03
GlaxoSmithKline GBP 6.16B 233M 2026-03
Halozyme Therapeutics USD 155.47M 21.01M 2026-03
Heron Therapeutics USD 54.57M 2.33M 2022-12
Ionis Pharmaceuticals USD 5.56M 4.49M 2026-03
Nektar Therapeutics USD 14.46M 1.78M 2024-06
Neurocrine Biosciences USD 64.5M 4.5M 2026-03
Novartis USD 6.29B 17M 2026-03